Agenda Archive - Page 22 of 1076 - Arena International

CLOSING KEYNOTE: Engineering tumor selectivity: The Rise of a Masked CD47 Biologic and a China-enabled development strategy

Evolution of masking technology to achieve protease-mediated, tumor-specific drug activation
Applications of masking technology in oncology and immunology, including the ubiquitous macrophage checkpoint, CD47, and cytokines
Development of a China-anchored early development path, including considerations of IITs, China IND, and US IND.

Reserved for event sponsor

Morning refreshments and networking

Chairperson’s closing remarks

Lunch, networking and prize draw

Sifting Through Chaos: Applying a Quality by Design Approach to Data Governance

Why applying a Quality by Design approach to data governance is needed to prevent the high costs of data sprawl
How data governance ensures Data is FAIR and meets ALCOA++ requirements to ensure data integrity and reliability
The components of a comprehensive data governance framework, including data definition, discovery, remediation, reporting, alerting, and retirements
How to implement a phased approach to transition from data chaos to control

Chairperson’s closing remarks

Networking drinks reception

Exploring outsourcing models to assess and determine best fit per trial

Reviewing outsourcing models from FSO, FSP and fully inhouse
Determining the best outsourcing model: pros, cons and assessment tips to consider
Selecting the right model and partners to fit your needs, optimizing cost and efficiency

Collaborating with quality assurance to improve efficiency and compliance

Reducing barriers and highlighting benefit of QA cross departmental collaboration
Embedding QA input into outsourcing strategy, contracting and oversight
Working together with QA for risk mitigation and inspection readiness
Vendor selection audit strategy